Search Results 3411-3420 of 17100 for pharmacogenetics
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
About this study. The purpose of this study is to assess operative and postoperative outcomes after aortic valve surgery, evaluate for changes in ascending ...
Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.
Cancer News from Mayo Clinic covering research breakthroughs, treatments, patient stories, and innovations advancing cancer care and outcomes.
At Mayo Clinic, biomedical engineer Benjamin Brinkmann, Ph.D., is developing tools and technologies that help reveal brain patterns — making epileptic seizures ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
About this study. This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to ...
This episode of "Tomorrow's Cure" explores the dramatic changes happening in pediatric care thanks to whole genome sequencing. Hear from Whitney Thompson, M.D., ...
ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...
Millions of people worldwide are affected by alcohol use disorder, a debilitating addiction that can disrupt daily life and overall health. Alcohol use disorder ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!